SIDE EFFECTS OF TREATMENT

Ms Annabel Crabb is one of Australia’s most beloved journalists. She is a multi-faceted writer
and broadcaster who ranges between federal politics, gender, current affairs, history and
cooking and is a sought-after speaker and presenter for her incisive and humorous
approach.

She is the creator and presenter of Ms Represented, and of the long-running political
interview series Kitchen Cabinet, a seventh season of which will air in 2023. She wrote and
presented the ground-breaking documentary series on life inside Australia’s Parliament
House, The House With Annabel Crabb. She also hosts ABC’s popular Australian history and
food series, Back In Time For Dinner. Annabel is a regular face on ABC TV’s election night
and Budget broadcasts and has a long history of appearances on ABC’s Insiders program,
including a stint as acting host in 2019.

She is a regular commentator across the ABC’s radio network. With friend and ABC
colleague Leigh Sales, Annabel hosts the podcast Chat 10 Looks 3, an independent podcast
in which the pair discusses books, film, culture, and cooking. Their first book together, Well Hello, was published in September 2021. Annabel won a Walkley Award for her
biographical work “Stop At Nothing: The Life And Adventures Of Malcolm Turnbull” and
has written several books including 2014 bestseller The Wife Drought.

Annabel boasts the awkward distinction of being Twitter’s most-followed Australian
journalist, with an audience of over half a million.

Ms Jenny Gilchrist is a Nurse Practitioner in Breast Oncology at Macquarie University
Hospital, one of only a few breast cancer specialist nurse practitioners in Australia.
She also works for the McGrath Foundation as the Chief Clinical Lead for the
Metastatic McGrath Breast Cancer nurses.
Jenny has twenty years’ nursing experience in oncology and palliative care, in both
adults and children, and holds an honorary position as Senior Clinical Lecturer at
Macquarie University. She a member on the board of directors of the Australasian
Society for Breast Diseases, a member of the strategic advisory group for BCNA and
a member of the scientific advisory committee for Breast Cancer Trials. Jenny is
heavily involved in the oncology curriculum of the Macquarie MD program and is
both a principal investigator and sub-investigator on several phase 1 – 4 breast
cancer clinical trials at Macquarie University, positions usually reserved for
medical practitioners.
Her clinical interests and passions include the care of people with breast cancer,
supportive care and the prevention of burnout in healthcare professionals. Jenny
also has a strong interest in clinical research, particularly that which aims to
improve patient symptoms, care and quality of life.

Ms Naveena Nekkalapudi is a member of the Breast Cancer Trials Consumer Advisory Panel and was diagnosed with triple negative breast cancer on Christmas eve in 2014.

Naveena has experienced both short and long-term side effects from breast cancer treatment, including nerve damage, chronic pain, cognitive impairment, the inability to work, and a weakened immune system which lead to further complications and hospitalisation.

Dr Nick Zdenkowski is a Medical Oncologist with a strong interest in breast cancer clinical practice and research. He is the Chair of the Breast Cancer Trials (BCT) Scientific Advisory Committee, Visiting Medical Officer at Maitland Private Hospital and Lake Macquarie Private Hospital, and is Conjoint Senior Lecturer in the Faculty of Medicine at the University of Newcastle.

Nick first became a member of BCT in 2010 and his role in clinical trials has included Chief Investigator, Study Chair, Co-Investigator, Steering Committee Member and external reviewer. In 2018 he became BCT’s Medical Advisor, assisting with the genesis of trials through to reporting of results.

Professor Bruce Mann is the Director of Research at Breast Cancer Trials, Professor of Surgery at The University of Melbourne and Director of the Breast Tumour Stream at the Victorian Comprehensive Cancer Centre.

He has facilitated clinical and translational research into all aspects of breast cancer via the development and maintenance of extensive clinical data collection.

His research interests focus on tailored screening and treatment for early breast cancer.  He was PI on Australia’s first decision impact study of Oncotype Dx, PI on a validation study of the DCISionRT assay for DCIS, national PI of the POSNOC study of axillary treatment for those with positive sentinel nodes, and is an instigator and principal investigator of the PROSPECT trial.